Trials / Completed
CompletedNCT04090320
CATERPILLAR™ Arterial Embolization Device Study
A Prospective, Multi-Center, Single-Arm Study Assessing the Clinical Use of the CATERPILLAR™ Arterial Embolization Device System for Arterial Embolization in the Peripheral Vasculature (CHRYSALIS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the performance and safety of the CATERPILLAR™ Arterial Embolization Device when used for arterial embolization in the peripheral vasculature.
Detailed description
This feasibility study is a prospective, multi-center, single-arm study of the CATERPILLAR™ Arterial Embolization Device. Up to twenty (20) subjects will be treated with the CATERPILLAR™ Arterial Embolization Device at up to 5 investigational sites in New Zealand and Australia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CATERPILLAR™ Arterial Embolization Device | Placement of the CATERPILLAR™ Arterial Embolization Device for patients requiring arterial embolization in the peripheral vasculature. |
Timeline
- Start date
- 2019-09-25
- Primary completion
- 2020-11-04
- Completion
- 2020-11-04
- First posted
- 2019-09-16
- Last updated
- 2021-01-15
Locations
5 sites across 2 countries: Australia, New Zealand
Source: ClinicalTrials.gov record NCT04090320. Inclusion in this directory is not an endorsement.